Showing results (81-90 of 115) with videos related to
Sort By:
Pageof 12
Journal of Viral Hepatitis|March 15, 2025
Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D InfectionSvenja Hardtke, Cihan Yurdaydin, Florin A Caruntu, et al.Journal of Viral Hepatitis|July 25, 2020
Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis deltaAnika Wranke, Svenja Hardtke, Benjamin Heidrich, et al.Journal of Clinical Gastroenterology|August 30, 2008
Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic surveyNurdan Tozun, Ozlen Atug, Nese Imeryuz, et al.Journal of Medical Virology|August 13, 2019
HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kitsOsman Yaşar, Ersin Karatayli, Güniz Cengiz, et al.United European Gastroenterology Journal|November 29, 2025
Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination TherapyCihan Yurdaydin, Julia Kahlhöfer, Florin Alexandru Caruntu, et al.The Journal of Pharmacology and Experimental Therapeutics|November 13, 2012
Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interactionToshihiko Nishimura, Toshiko Nishimura, Yajing Hu, et al.Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.Hepatology (Baltimore, Md.)|September 21, 2018
Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson DiseasePeter Ferenci, Wolfgang Stremmel, Anna Członkowska, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2024
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International NetworkAnika Wranke, Cirley Lobato, Emanoil Ceausu, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2020
Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II studyBirgit Bremer, Olympia E Anastasiou, Svenja Hardtke, et al.Pageof 12